fbpx

The Jewish Drug Dealers Who Are Saving Lives

[additional-authors]
January 25, 2021
Photo by boonchai wedmakawand/Getty Images

Jewish Contributions to Humanity #10:
Original research by Walter L. Field.
Sponsored by Irwin S. Field.


August von Wassermann (1866-1925). b. Bamberg, Germany.  The immunologist. 

In 1906, bacteriologist and immunologist August von Wassermann created the first reliable test for detecting syphilis, a sexually transmitted disease. The Wasserman test, which was developed at the Robert Koch Institute for Infectious Diseases identifies an antibody that’s unique to syphilis, lupus, malaria, and tuberculosis. This test formed the basis for subsequent tests used in the detection of these diseases. In 1921 Wasserman became the first recipient of the Aronson Prize for his immunological achievements.


Bela Schick (1877-1967). b. Balatonboglár, Hungary. Sticking it to diphtheria.

Raised in Hungary but spending most of his clinical career in New York City, Bela Schick created the Schick test to identify diphtheria, a potentially fatal disease that originates in the throat and still kills thousands of people per year. Schick created the test in 1910, when diphtheria was a feared disease and vaccinations for it were in low supply, making it crucial to only vaccinate children with preexistent susceptibility, and not those who were naturally immune from diphtheria. Schick’s test identified at-risk children by injecting a tiny amount of diluted diphtheria into their arm. In susceptible children, the injection site would become red and swollen. He led a massive and successful five-year public relations campaign to persuade as many parents as possible to test their children for susceptibility.


Gertrude Elion (1918-1999). b. New York City. Nobel Prize in Physiology or Medicine 1988. A pharmaceutical genius. 

Spurred by the death of her grandfather from cancer, Gertrude Elion, at 15, decided to devote her career to making people healthier. In her 20s she began research at what is now the pharmaceutical giant GlaxoSmithKline, eschewing a PhD so that she could continue her lab work full-time. By the time her career ended, she was responsible for the creation of Purinethol, the first Leukemia treatment, Imuran, a crucial drug for organ transplants, Daraprim, a crucial malaria treatment, Septra, vital in treating infections of the urinary and respiratory tracts, Zovirax, which is used to treat herpes, and AZT, the first ever drug approved by the U.S. government in treatment of HIV. Several of the drugs she helped create are on the WHO’s Model List of Essential Medicines, which is a list of drugs that any society must have readily accessible in order to maintain basic standards of health. 

Did you enjoy this article?
You'll love our roundtable.

Editor's Picks

A Night of Gratitude Honoring Dennis Prager

Latest Articles

What Isaac the Blind Sees

Isaac is not merely a blind man with insight; he is a blind man who has seen beyond this world.

Print Issue: What Happened? | November 13, 2026

A story of bipartisan support that gradually became a story of one-party support, until it flips entirely and becomes once again a story of consensus – this time, of bipartisan opposition.

Why Are We Even Here?

When we’re tempted to ask, Lamah zeh anochi? — Why am I here? What’s the point? — we can remind ourselves of the extraordinary goodness that exists in the world. And, even more importantly, we can become part of it.

Leo David Honored as FIDF Gala Raises

Throughout the years, David has donated millions of dollars to numerous causes, but FIDF has always held a particularly special place in his heart.

What If Jewish Americans Just Showed Up?

We mourn on Oct. 7, but Nov. 8 gave us something to celebrate: a community that showed up, on its feet, public and proud. Now we need to make that response a habit.

Genocide and International Relations

The book casts its net far and wide, from debates within the field of research itself to the analysis of genocidal events across the past century.

A Concrete Case for Hope

Over the last month, Americans and Israelis voted in elections that were consequential to the characters of both countries. For many, these elections represented inflection points, signaling the directions their respective societies will take moving forward.

AIPAC Isn’t the Problem. It’s Part of the Solution.

The future of the U.S.-Israel relationship will not be secured by winning one more primary. It will depend on whether Americans understand why Israel matters, why Jewish self-determination is legitimate, and why the alliance benefits both nations.

More news and opinions than at a Shabbat dinner, right in your inbox.